Report Digest: A Trio Of Drug Delivery Technologies
In this episode of Report Digest, UK-based reporter Barnaby Pickering speaks to analyst Carrie Neptune about three Meddevicetracker reports on drug delivery technology.
You may also be interested in...
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
Dexcom has expanded the availability of its G7 sensor to five new markets, including the UK and Germany. FDA approval in the US has been delayed by software changes.
PocDoc and Lifelight have won the Novartis’ Heart Health Catalyst program and will work on smartphone-based lipid-measuring and clinical vital signs tools for evaluating cardiac health on a population level.